Guggenheim Russell Top 50® Mega Cap ETF

Most Recent

  • uploads///Chart
    Earnings Report

    Johnson & Johnson’s Revenues Rose 11.5% in 4Q17

    Johnson & Johnson (JNJ) reported 11.5% revenue growth to ~$20.2 billion during 4Q17 compared to revenues of ~$18.1 billion in 4Q16. JNJ surpassed its EPS and revenue estimates.

    By Mike Benson
  • uploads///Chart  Diabetes
    Company & Industry Overviews

    Merck & Co.’s Diabetes Products in 3Q17

    The combined revenues for Januvia and Janumet decreased 2% at constant exchange rates to $1.52 billion in 3Q17 compared to $1.55 billion in 3Q16.

    By Mike Benson
  • uploads///Chart
    Company & Industry Overviews

    Johnson & Johnson’s Pharmaceutical Business Performance in 3Q17

    JNJ’s pulmonary hypertension products were acquired from Actelion in 2Q17 and reported revenues of $670.0 million during 3Q17.

    By Mike Benson
  • uploads///Medical Devices
    Company & Industry Overviews

    How Johnson & Johnson’s Medical Devices Business Performed in 3Q17

    In 3Q17, JNJ’s Medical Devices business saw revenues of $6.6 billion, which is ~7% higher YoY (year-over-year) and 2% lower QoQ (quarter-over-quarter).

    By Daniel Collins
  • uploads///Chart
    Company & Industry Overviews

    What Contributed to Pfizer’s Growth in 2016?

    The key performers of Pfizer’s product portfolio include Lyrica, Ibrance, Xeljanz, and Eliquis from the Innovative Health business.

    By Mike Benson
  • uploads///globalization
    Company & Industry Overviews

    How Is Medtronic’s Globalization Strategy Driving Its Growth?

    Medtronic’s (MDT) growth is driven by three of the company’s core strategies—therapy innovation, globalization, and economic value.

    By Sarah Collins
  • uploads///Weekly Performance
    Macroeconomic Analysis

    PowerShares QQQ’s Subsectors Generate Negative Returns

    QQQ closed at $102.16 with a return of -1.19% on Friday, September 4, 2015, generating a loss of 3.28% for the week.

    By Parker Thomas
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.